Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events.
Kazuhiko IkedaKeiji MinakawaKenichi YamaharaMinami Yamada-FujiwaraYoshiki OkuyamaShin-Ichiro FujiwaraRie YamazakiHeiwa KanamoriTohru IsekiTokiko Nagamura-InoueKazuaki KamedaKazuhiro NagaiNobuharu FujiiTakashi AshidaAsao HiroseTsutomu TakahashiHitoshi OhtoKoki UedaRyuji TanosakiPublished in: Transfusion (2022)
Infusion of a CP-1-containing PBSC product is feasible with the respect of HCI-AEs.